122 related articles for article (PubMed ID: 3552018)
21. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
Shim HS; Jung WH; Kim H; Park K; Cho NH
APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical detection of prolactin binding sites in fine needle aspiration smears of breast lesions.
Tandon S; Agarwal PK; Mishra KL; Goel A; Kumar S
Indian J Med Res; 1993 Apr; 98():61-4. PubMed ID: 8344732
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
24. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
[TBL] [Abstract][Full Text] [Related]
25. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
[TBL] [Abstract][Full Text] [Related]
26. [Relation of epithelial metaplasia and calcification with epithelial proliferation in fibrocytic breast disease].
Savjak D; Pikula B
Med Arh; 1991; 45(1-2):59-62. PubMed ID: 1366322
[TBL] [Abstract][Full Text] [Related]
27. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
Hanna W; Kahn HJ; Andrulis I; Pawson T
Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
[TBL] [Abstract][Full Text] [Related]
28. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
[TBL] [Abstract][Full Text] [Related]
29. Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.
diFlorio-Alexander RM; Marotti JD; Bond JS; Schwab MC; Memoli VA; Wells WA; Poplack SP
AJR Am J Roentgenol; 2015 Jan; 204(1):211-8. PubMed ID: 25539259
[TBL] [Abstract][Full Text] [Related]
30. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
31. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
Schurz B
Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
Egan MJ; Newman J; Crocker J; Collard M
Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody B72.3 in benign breast lesions.
Soomro S; Shousha S
J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
[TBL] [Abstract][Full Text] [Related]
34. Is cystic disease related to breast cancer?
Haagensen DE
Am J Surg Pathol; 1991 Jul; 15(7):687-94. PubMed ID: 2058763
[TBL] [Abstract][Full Text] [Related]
35. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies 323/A3 and Ca1 identify a paracrine function of breast carcinoma on adjacent benign histological components.
Courtney SP; Williams S; Mansel RE
Br J Cancer Suppl; 1990 Jul; 10():92-5. PubMed ID: 1696492
[TBL] [Abstract][Full Text] [Related]
37. The microenvironment of human breast with clinical cancer.
Sarnelli R; Squartini F
Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
39. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
40. Steroid receptors in benign breast disease, gross cystic disease and fibroadenoma.
Nardelli GB; Lamaina V; Siliotti F
Clin Exp Obstet Gynecol; 1987; 14(1):10-5. PubMed ID: 3815831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
